Emerging data suggest Retatru tide , a dual stimulator targeting both the gut-brain axis and GIP , could offer a promising development for obesity management . Preliminary patient investigations have shown substantial reductions in visceral tissue, potentially outperforming existing obesity treatments. Nevertheless , further assessment is needed to